Cash & equivalents increased 221.8%
Cash & equivalents changed +221.8% from the comparable as-filed period.
Ranked by interpretable importance, issuer history, magnitude, and accounting profile. No directional recommendation.
Cash & equivalents changed +221.8% from the comparable as-filed period.
Revenue changed +21.6% from the comparable as-filed period.
Operating income changed -22.9% from the comparable as-filed period.
Research & development changed +26.5% from the comparable as-filed period.
Stock-based compensation changed +141.0% from the comparable as-filed period.
SBC / revenue changed +701 basis points from the comparable as-filed period.
Selling, general & administrative changed +25.0% from the comparable as-filed period.
Operating margin changed -21 basis points from the comparable as-filed period. This reverses 2 consecutive comparable moves in the opposite direction.
Net income changed +113.2% from the comparable as-filed period. Relative percentage is de-emphasized because the comparison has a sign change.
Inventory / revenue changed -114 basis points from the comparable as-filed period.
Inventory changed +12.4% from the comparable as-filed period.
Method Importance combines metric-family relevance, magnitude, issuer-history unusualness, persistence, and financial-statement significance. It is analytical prioritization, not a legal materiality conclusion or investment signal.